FDA will not be able to implement its proposed OTC monograph reform and user fee rules on the Oct. 1 start of federal fiscal year 2018 as those changes were contingent on Congress passing enabling legislation.
Legislation to change the monograph process and authorize user fees to pay for FDA’s work has not made it beyond...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?